Randomized controlled trial of remote endarterectomy versus endovascular intervention for TransAtlantic Inter-Society Consensus II D femoropopliteal lesions

Gabrielli, Roberto; Rosati, Maria Sofia; Vitale, Silvio; Baciarello, Giulia; Siani, Andrea; Chiappa, Roberto; Caselli, Giovanni; Irace, L

doi:10.1016/j.jvs.2012.06.081

Cited by 34 publications

(35 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Möglicherweise haben PTFE-gecoverte Stentgrafts eine bessere Prognose (271). Eine RCT bei Patienten mit CLI und femoropoplitealen TASC B-und C-Läsionen wurde allerdings vorzeitig beendet, da die Offenheit von Bypasses nach 1 Jahr mit 95 % signifikant höher war als die von PTFE-Stentgrafts (46 %) (396).…”

Section: Gefäßchirurgie Der Beckenarterienunclassified

S3-Leitlinie PAVK - Diagnostik, Therapie und Nachsorge der peripheren arteriellen Verschlusskrankheit

2016

Vasa

View full text Add to dashboard Cite

Gültigkeitsdauer und Fortschreibung Diese Leitlinie wurde im September 2015 durch den Vorstand der DGA und durch die Vorstände der korrespondierenden Fachgesellschaften verabschiedet und ist bis zur nächsten Überarbeitung bzw. spätestens bis 30.09.2020 gültig. Verantwortlich für die kontinuierliche Fortschreibung, Aktualisierung und Bekanntmachung ist die DGA. BESONDERER HINWEIS Die Medizin unterliegt einem fortwährenden Entwicklungsprozess, sodass alle Angaben, insbesondere zu diagnostischen und therapeutischen Verfahren, immer nur dem Wissensstand zurzeit der Drucklegung der Versorgungsleitlinie entsprechen können. Hinsichtlich der angegebenen Empfehlungen zur Therapie und der Auswahl sowie Dosierung von Medikamenten wurde die größtmögliche Sorgfalt beachtet. Gleichwohl werden die Benutzer aufgefordert, die Beipackzettel und Fachinformationen der Hersteller zur Kontrolle heranzuziehen und im Zweifelsfall einen Spezialisten zu konsultieren. Fragliche Unstimmigkeiten sollen bitte im allgemeinen Interesse der DGA-Redaktion mitgeteilt werden. Der Benutzer selbst bleibt verantwortlich für jede diagnostische und therapeutische Applikation, Medikation und Dosierung. In dieser Leitlinie sind eingetragene Warenzeichen (geschützte Warennamen) nicht besonders kenntlich gemacht. Es kann also aus dem Fehlen eines entsprechenden Hinweises nicht geschlossen werden, dass es sich um einen freien Warennamen handelt. Das Werk ist in allen seinen Teilen urheberrechtlich geschützt. Jede Verwertung außerhalb der Bestimmung des Urhebergesetzes ist ohne schriftliche Zustimmung der DGA-Redaktion unzulässig und strafbar. Kein Teil des Werkes darf in irgendeiner Form ohne schriftliche Genehmigung der DGA-Redaktion reproduziert werden. Dies gilt insbesondere für Vervielfältigungen, Übersetzungen, Mikroverfilmungen und die Einspeicherung, Nutzung und Verwertung in elektronischen Systemen, Intranets und dem Internet.

show abstract

Section: Gefäßchirurgie Der Beckenarterienunclassified

S3-Leitlinie PAVK - Diagnostik, Therapie und Nachsorge der peripheren arteriellen Verschlusskrankheit

2016

Vasa

View full text Add to dashboard Cite

show abstract

“…Previous studies reported no significant difference in complications rates between the subintimal and intraluminal groups. 12, 16 As the major complication rates of subintimal angioplasty in the previous studies varied from 0% to 13%, 7,12,15,16 the periprocedural complication rates (4.1% for major complicates and 9.1% for all complications) observed in this study appear to be still rather low.…”

Section: Mid-term Outcomesmentioning

confidence: 49%

Clinical Outcomes of Subintimal vs. Intraluminal Revascularization Approaches for Long Femoropopliteal Occlusions in a Korean Multicenter Retrospective Registry Cohort

Kim

Ahn

et al. 2018

Circ J

View full text Add to dashboard Cite

a totally occluded segment via intentional creation of a subintimal channel. Since this approach was first described by Bolia et al in 1989, 3 the subintimal approach has been widely used to overcome long chronic arterial occlusions. 2,4-6 Furthermore, the more recent introduction of re-entry devices and the adoption of bidirectional wiring approaches have improved the technical success of the subintimal approach for femoropopliteal lesions. 7 In addition, implantation of self-expanding nitinol stents further contributes to increased patency rates after this procedure. 1,7-9 Despite these recent advances in the outcomes of the subintimal T he femoropopliteal artery is the longest arterial segment that is exposed to various forces induced by leg movements and frequently affected by the atherosclerotic process. Over the past decade, self-expanding nitinol stents have significantly improved the outcomes of endovascular therapy for femoropopliteal artery disease; 1 however, the technical success and durability of patency after endovascular treatment in this arterial segment have been challenged by common lesion characteristics, such as long occlusions and calcifications. 2 The subintimal approach is a technique that recanalizes Background: There are limited data comparing the outcomes of subintimal vs. intraluminal approach in the treatment of long femoropopliteal artery occlusions. The objective of this study was to investigate the efficacy and safety of the subintimal approach for long femoropopliteal artery occlusions.

show abstract

“…After RSFAE primary, assisted primary, and secondary patencies are evidently higher than after an endovascular treatment. 11 If the saphenous vein is not usable, RSFAE should be regarded as a better choice, because it is mini-invasive and prosthetic graft material cannot be necessarily used. 12…”

Section: Resultsmentioning

confidence: 99%

Better treatment option in chronic superficial femoral artery occlusive disease: comparison of methods (meta-analysis)

Starodubtsev¹,

Karpenko²,

Ленько³

et al. 2019

J Cardiovasc Thorac Res

View full text Add to dashboard Cite

Introduction: The objective is to evaluate the frequency of primary obstruction events (PrO) during one-year follow-up after performing excisional atherectomy with the SilverHawk/TurboHawk atherectomy device (S/TH) or remote superficial femoral artery endarterectomy (RSFAE) in patients with the chronic superficial femoral artery occlusive disease (СSFAOD). Methods: We included all randomized clinical trials (RCTs) and not-RCTs concerning the treatment of patients with СSFAOD after S/TH and RSFAE without duration. Results: Twenty-nine items (1990-2017) were discovered; 27 articles on the levels of evidence were included in qualitative synthesis; 9 studies (meta-analysis) were included in quantitative synthesis. The results of 2762 patients’ treatment were summed up in our analysis (1422 patients S/TH; 1340 patients RSFAE). All included reports were at low risk of bias. According to the criterion "frequency of PrO" during one-year follow-up, the pooled Hazard Ratios indicate significant favours of S/TH if compared it with RSFAE (HR= 0.66 (0.57 to 0.76, P < 0.00001), I2 = 9%). Conclusion: Our study showed that S/TH with the SpiderFX device (distal embolic protection) are safe and effective treatment option for short lesion (<15 cm) in patients with СSFAOD. The usage of S/TH methods significantly reduced number of PrO if compared it with RSFAE. In long-segment lesion (>15 cm) in patients with СSFAOD, RSFAE may be considered better than an endovascular procedure. But still it is necessary to conduct well-planned randomized studies to determine effectiveness and safety of the compared methods (S/TH and RSFAE) in patients with long-segment lesion (>15 cm).

show abstract

Randomized controlled trial of remote endarterectomy versus endovascular intervention for TransAtlantic Inter-Society Consensus II D femoropopliteal lesions

Cited by 34 publications

References 33 publications

S3-Leitlinie PAVK - Diagnostik, Therapie und Nachsorge der peripheren arteriellen Verschlusskrankheit

S3-Leitlinie PAVK - Diagnostik, Therapie und Nachsorge der peripheren arteriellen Verschlusskrankheit

Clinical Outcomes of Subintimal vs. Intraluminal Revascularization Approaches for Long Femoropopliteal Occlusions in a Korean Multicenter Retrospective Registry Cohort

Better treatment option in chronic superficial femoral artery occlusive disease: comparison of methods (meta-analysis)

Contact Info

Product

Resources

About